Duopharma Biotech Bhd (7148) - Total Liabilities

Latest as of March 2026: RM689.10 Million MYR ≈ $173.01 Million USD

Based on the latest financial reports, Duopharma Biotech Bhd (7148) has total liabilities worth RM689.10 Million MYR (≈ $173.01 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Duopharma Biotech Bhd net asset momentum to track the company's year-over-year net asset growth rate.

Duopharma Biotech Bhd - Total Liabilities Trend (2006–2025)

This chart illustrates how Duopharma Biotech Bhd's total liabilities have evolved over time, based on quarterly financial data. See Duopharma Biotech Bhd (7148) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Duopharma Biotech Bhd Competitors by Total Liabilities

The table below lists competitors of Duopharma Biotech Bhd ranked by their total liabilities.

Company Country Total Liabilities
ACOTEC SCIEN.H. DL-00001
F:7W3
Germany €392.01 Million
Rimini Street Inc
NASDAQ:RMNI
USA $380.14 Million
Scpharmaceuticals Inc
NASDAQ:SCPH
USA $101.57 Million
Biofarm Bucure
RO:BIO
Romania RON85.86 Million
ANTENGENE CORP. DL-0001
F:722
Germany €614.60 Million
Neuberger Berman IMF Inc
NYSE MKT:NBH
USA $231.69 Million
Value Line Inc
NASDAQ:VALU
USA $43.20 Million
Accent Group Ltd
AU:AX1
Australia AU$924.76 Million

Liability Composition Analysis (2006–2025)

This chart breaks down Duopharma Biotech Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Duopharma Biotech Bhd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.62 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.91 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.48 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Duopharma Biotech Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Duopharma Biotech Bhd (2006–2025)

The table below shows the annual total liabilities of Duopharma Biotech Bhd from 2006 to 2025.

Year Total Liabilities Change
2025-12-31 RM690.68 Million
≈ $173.41 Million
+3.42%
2024-12-31 RM667.85 Million
≈ $167.67 Million
+1.49%
2023-12-31 RM658.01 Million
≈ $165.21 Million
+16.11%
2022-12-31 RM566.70 Million
≈ $142.28 Million
+4.92%
2021-12-31 RM540.13 Million
≈ $135.61 Million
+30.27%
2020-12-31 RM414.61 Million
≈ $104.10 Million
+6.30%
2019-12-31 RM390.05 Million
≈ $97.93 Million
+9.77%
2018-12-31 RM355.34 Million
≈ $89.21 Million
+57.66%
2017-12-31 RM225.38 Million
≈ $56.58 Million
+8.90%
2016-12-31 RM206.95 Million
≈ $51.96 Million
+12.64%
2015-12-31 RM183.73 Million
≈ $46.13 Million
+536.91%
2014-12-31 RM28.85 Million
≈ $7.24 Million
+25.41%
2013-12-31 RM23.00 Million
≈ $5.78 Million
-16.43%
2012-12-31 RM27.53 Million
≈ $6.91 Million
-16.77%
2011-12-31 RM33.08 Million
≈ $8.30 Million
-14.34%
2010-12-31 RM38.61 Million
≈ $9.69 Million
+26.07%
2009-12-31 RM30.63 Million
≈ $7.69 Million
+54.46%
2008-12-31 RM19.83 Million
≈ $4.98 Million
+51.11%
2007-12-31 RM13.12 Million
≈ $3.29 Million
-3.36%
2006-12-31 RM13.58 Million
≈ $3.41 Million
--

About Duopharma Biotech Bhd

KLSE:7148 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$304.31 Million
RM1.21 Billion MYR
Market Cap Rank
#14532 Global
#173 in Malaysia
Share Price
RM1.26
Change (1 day)
-0.79%
52-Week Range
RM1.19 - RM1.55
All Time High
RM2.86
About

Duopharma Biotech Berhad, together with its subsidiaries, researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally. It offers consumer healthcare products, including vitamins, minerals, and supplements under the Flavettes, PROVITON, PROVITON STR, CHAMPS, and Naturalle brand names; analgesics and antitussives… Read more